Hi Pigo,This company is a long way of moving into the big league.After the feasablity assessment ( 6 months ) & if successful they will gain approval to enroll & trial 400 to450 patients ( pivotal trials ).This process will take some years & plenty of cash to achieve success.Shareholders have perceived the recent move by the board to receive hefty increases in their remuneration & bonus share issues as a board with a big capital burn rate This coupled with the giveaway price for 30 per cent of the company have resulted in the current exodus from the market.I don't believe the NASDAQ listing will be a solver bullet & doubt that this board will take us over the line.
SHC Price at posting:
3.8¢ Sentiment: Sell Disclosure: Held
